Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Sawit Sumbermas Sarana Tbk (SSMS) Price & Performance

UBC Medical Indonesia Tbk.Trade
Sawit Sumbermas Sarana TbkTrade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Sawit Sumbermas Sarana Tbk — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Sawit Sumbermas Sarana Tbk trades at Rp1,195 (market cap 11.38T, 9.52M 24h volume). The key difference: Sawit Sumbermas Sarana Tbk is far larger — about 16.5× UBC Medical Indonesia Tbk.'s market cap, and Sawit Sumbermas Sarana Tbk is more actively traded (9.52M versus 635.5K). Which is the better fit depends on your goals.

LABSSSMS
Market Cap
691.25B11.38T
Volume
635.5K9.52M
Lot
6.36K95.2K
Turnover
110.15M11.42B
Average Price
173.331,199.09
Value
110.15M11.42B
Indicative Equilibrium Price
1741,195
Indicative Equilibrium Volume
50300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SSMS
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Sawit Sumbermas Sarana Tbk

PT Sawit Sumbermas Sarana Tbk (the Company) was established in Jakarta based on the Notarial Deed No. 51 of Enimarya Agoes Suwarko, S.H., dated November 22, 1995.

Read more on SSMS